
36.75 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 11.26 Today|||52-Week Range 49.00 | -2.03% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP $723.6M |
Albireo Pharma, Inc. 10 Post Office Square Boston Massachusetts 02109 |
Ronald H. W. Cooper | President, Chief Executive Officer & Director |
Simon John Harford | Chief Financial Officer & Treasurer |
Jan Peter Mattsson | Chief Scientific Officer, Managing Director-Sweden |
Patrick Taylor Horn | Chief Medical Officer |
Per-Göran Gillberg | Vice President-Development & Owner |